Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Kuip EJM"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł :
Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer.
Autorzy :
Kroon LL; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), PO box 19079, 3501 DB, Utrecht, The Netherlands.; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
van Roij J; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), PO box 19079, 3501 DB, Utrecht, The Netherlands.; Department of Medical and Clinical Psychology, CoRPS - Center of Research on Psychology in Somatic Diseases, Tilburg University, Tilburg, The Netherlands.; Netherlands Association for Palliative Care (PZNL), Utrecht, The Netherlands.; Department of Psychology, Pantein, Boxmeer, The Netherlands.
Korfage IJ; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
van den Beuken-van Everdingen MHJ; Center of Expertise Palliative Care, Maastricht University Medical Center, Maastricht, The Netherlands.
den Boer MO; Department of Medical Oncology, Laurentius Hospital, Roermond, The Netherlands.
Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.
de Graeff A; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Hendiks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.
Hunting JCB; Department of Medical Oncology, St. Antonius Hospital, Utrecht, The Netherlands.
de Jong WK; Department of Pulmonology, Hospital Gelderse Vallei, Ede, The Netherlands.
Kuip EJM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
van Leeuwen L; Department of Medical Oncology, Diakonessenhuis, Utrecht, The Netherlands.
van Lindert ASR; Department of Pulmonology, University Medical Center Utrecht, Utrecht, The Netherlands.
Mandigers CMPW; Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Nieboer P; Department of Medical Oncology, Wilhelmina Hospital Assen, Assen, The Netherlands.
van der Padt-Pruijsten A; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
Smilde TJ; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Sommeijer DW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Department of Internal Medicine, FlevoHospital, Almere, The Netherlands.
Thijs MF; Department of Medical Oncology, Ikazia Hospital, Rotterdam, The Netherlands.
Tiemessen MA; Department of Pulmonology, Dijklander Hospital, Hoorn, The Netherlands.
Vos AH; Department of Medical Oncology, Bernhoven Hospital, Uden, The Netherlands.
Vreugdenhil A; Department of Medical Oncology, Maxima Medical Center, Eindhoven, The Netherlands.
Werner PT; Department of Medical Oncology, VieCuri Medical Center, Venlo, The Netherlands.
van Zuylen L; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
van de Poll-Franse LV; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), PO box 19079, 3501 DB, Utrecht, The Netherlands.; Department of Medical and Clinical Psychology, CoRPS - Center of Research on Psychology in Somatic Diseases, Tilburg University, Tilburg, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Raijmakers NJH; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), PO box 19079, 3501 DB, Utrecht, The Netherlands. .; Netherlands Association for Palliative Care (PZNL), Utrecht, The Netherlands. .
Pokaż więcej
Corporate Authors :
eQuiPe study group
Źródło :
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2021 Jun; Vol. 15 (3), pp. 380-385. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy.
Autorzy :
Kuip EJM; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. evelien.kuip@radboudumc.nl.; Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6500 HB Nijmegen, The Netherlands. evelien.kuip@radboudumc.nl.; Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6500 HB Nijmegen, The Netherlands. evelien.kuip@radboudumc.nl.
Oldenmenger WH; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
Verduijn GM; Department of Radiation Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
Thijs-Visser MF; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
van Meerten E; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .; Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .
van der Rijt CCD; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. .; Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT Utrecht, The Netherlands. .
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2018 Nov 15; Vol. 10 (11). Date of Electronic Publication: 2018 Nov 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer.
Autorzy :
Kuip EJM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Anesthesiology, Pain and Palliative Care, Radboud University Medical Center, Nijmegen, the Netherlands.
Oldenmenger WH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Thijs-Visser MF; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Van der Rijt CCD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2018 Jun 08; Vol. 13 (6), pp. e0198289. Date of Electronic Publication: 2018 Jun 08 (Print Publication: 2018).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Analgesics, Opioid/*administration & dosage
Cancer Pain/*drug therapy
Fentanyl/*administration & dosage
Smoking/*adverse effects
Administration, Cutaneous ; Aged ; Analgesics, Opioid/pharmacokinetics ; Body Mass Index ; Cancer Pain/blood ; Cohort Studies ; Female ; Fentanyl/pharmacokinetics ; Humans ; Male ; Middle Aged ; Prospective Studies ; Transdermal Patch
Czasopismo naukowe
Tytuł :
Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl.
Autorzy :
Kuip EJM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Anesthesiology, Pain and Palliative Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Oldenmenger WH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Visser-Thijs MF; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Van der Rijt CCD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Koolen SW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2018 Apr 06; Vol. 9 (26), pp. 18269-18276. Date of Electronic Publication: 2018 Apr 06 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer.
Autorzy :
Westdorp H; Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kuip EJM; Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kramers C; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Vissers KCP; Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Journal of pain and symptom management [J Pain Symptom Manage] 2018 Apr; Vol. 55 (4), pp. e6-e8. Date of Electronic Publication: 2017 Nov 22.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Analgesics, Opioid/*therapeutic use
Antineoplastic Agents/*therapeutic use
Fentanyl/*therapeutic use
Oxycodone/*therapeutic use
Phenylthiohydantoin/*analogs & derivatives
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Aged ; Bone Neoplasms/drug therapy ; Bone Neoplasms/secondary ; Drug Interactions ; Humans ; Male ; Middle Aged ; Pain/drug therapy ; Pain Management/methods ; Palliative Care/methods ; Phenylthiohydantoin/therapeutic use ; Prostatic Neoplasms, Castration-Resistant/pathology
Raport
Tytuł :
Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasma.
Autorzy :
de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: .
Kuip EJM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Lam MH; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2018 Feb 05; Vol. 149, pp. 475-481. Date of Electronic Publication: 2017 Nov 17.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Analgesics, Opioid/*analysis
Chromatography, High Pressure Liquid/*methods
Fentanyl/*analysis
Morphine Derivatives/*blood
Tandem Mass Spectrometry/*methods
Acetonitriles/chemistry ; Analgesics, Opioid/pharmacology ; Analgesics, Opioid/therapeutic use ; Calibration ; Cancer Pain/drug therapy ; Chromatography, High Pressure Liquid/instrumentation ; Dose-Response Relationship, Drug ; Fentanyl/pharmacology ; Humans ; Morphine Derivatives/pharmacology ; Reference Standards ; Reproducibility of Results ; Solid Phase Extraction ; Tandem Mass Spectrometry/instrumentation
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies